Blackstone Close to Finalizing $4B Acquisition of MacLean Power Systems, According to Bloomberg
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 26 2025
0mins
Blackstone's Acquisition: Blackstone is nearing a $4 billion deal to acquire MacLean Power Systems from Centerbridge Partners.
Announcement Timeline: The announcement of the purchase could come as soon as next week.
Competitive Landscape: Blackstone has outperformed other potential buyers, including ABB, in securing the deal.
Market Implications: This acquisition highlights Blackstone's aggressive investment strategy in the power systems sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BX
Wall Street analysts forecast BX stock price to rise
12 Analyst Rating
5 Buy
7 Hold
0 Sell
Moderate Buy
Current: 118.120
Low
166.00
Averages
176.60
High
205.00
Current: 118.120
Low
166.00
Averages
176.60
High
205.00
About BX
Blackstone Inc. is an alternative asset manager. Its asset management includes global investment strategies focused on real estate, private equity, infrastructure, life sciences, growth equity, credit, real assets, secondaries, and hedge funds. Its Real Estate segment comprises its management of opportunistic real estate funds, Core+ real estate funds, and real estate debt strategies. Its Private Equity segment includes its management of flagship Corporate Private Equity funds, sector and geographically focused Corporate Private Equity funds, core private equity funds, an investment platform, and others. Its Credit & Insurance segment consists of Blackstone Credit & Insurance, which is organized into three overarching strategies: private corporate credit, liquid corporate credit and infrastructure and asset-based credit. Its Multi-Asset Investing segment is organized into four investment platforms: Absolute Return, Multi-Strategy, Total Portfolio Management, and Public Real Assets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Apogee Therapeutics Partners with Blackstone for $1.3B Financing
- Financing Collaboration: Apogee Therapeutics has entered into a strategic financing collaboration with Blackstone Life Sciences, providing up to $1.3 billion in flexible, non-dilutive capital, including $800 million in synthetic royalty funding and $500 million in senior debt, aimed at supporting the development and commercialization of its advanced drug, zumilokibart.
- Royalty Structure: Blackstone will provide up to $800 million in synthetic royalty funding in exchange for low-to-mid single-digit tiered royalties on worldwide annual sales of zumilokibart for a term of 15 years, which is expected to generate long-term revenue for the company.
- Improved Cash Flow Outlook: As a result of this financing agreement, Apogee has removed its cash runway end date guidance, and combined with its current total cash of $1.3 billion, this transaction positions the company to achieve a self-sustainable financial profile without the need for future equity financing.
- Market Reaction: Despite the significant funding support from the agreement, the market reacted negatively, with Apogee's shares falling over 27% in premarket trading, indicating investor concerns regarding the company's future prospects.
See More
Medline Prices Upsized Secondary Offering of 72.6M Shares
- Upsized Offering: Medline announced an upsized secondary offering of approximately 72.6 million Class A shares at $37 per share, indicating sustained market demand despite the company not participating in the offering, which is expected to close on May 28.
- Underwriter Option: The selling shareholders granted underwriters a 30-day option to purchase up to an additional 10.8 million shares, enhancing market liquidity and investor confidence in Medline's stock.
- Stock Performance: Medline shares closed at $37.1 on Thursday and rose 0.8% in premarket trading on Friday, reflecting a positive market reaction to the offering announcement, which may attract more investor interest.
- Key Shareholder Background: The selling shareholders include affiliates of Blackstone, Hellman & Friedman, and a wholly owned subsidiary of the Abu Dhabi Investment Authority, showcasing strong institutional confidence and support for Medline.
See More
Private Credit Defaults Reach Record Highs Amid Rising Yields
- Rising Default Rates: Fitch Ratings reported that the U.S. private credit default rate reached a record 6.0% for the twelve months ending April 2026, up from 5.7% in March 2025, indicating a significant increase in credit risk within the sector.
- Market Tightening: As inflation concerns escalate, lenders are tightening covenant structures and standards, with KBRA noting that the market's 'narrowing margin for error' could lead to more loan defaults and refinancing challenges.
- Increased Investor Redemptions: Data from Robert A. Stanger & Co shows that redemptions from unlisted business development companies surpassed fundraising in Q1, resulting in the Stanger NL BDC Total Return Index posting its first negative return since 2022, reflecting declining investor confidence in private credit.
- Poor Performance of Major Firms: An analysis by S&P Global revealed that sentiment among the big four private equity firms has plummeted to a multiyear low, with KKR experiencing a total return decline of 19.4%, highlighting the industry's overall weak performance amid rising default rates and market uncertainty.
See More
Nvidia's Quarterly Report Sparks Market Skepticism
- Sustained Demand: CEO Jensen Huang stated that demand for Nvidia's products has gone parabolic, yet the muted market reaction to the quarterly report indicates investor skepticism about future growth, which could negatively impact stock performance.
- Data Center Business Segmentation: Nvidia has introduced a new reporting framework that segments its data center business into hyperscale and non-hyperscale customers, including AI clouds and industrial enterprises, suggesting that this segment could become a significant driver of future growth and alter market dynamics.
- Market Share Advantage: Huang emphasized that Nvidia holds nearly a 100% share in the AI cloud and industrial enterprise markets, particularly in inference computing, where rapid growth is expected to further solidify its market leadership and enhance long-term profitability.
- Valuation Appeal: Despite Nvidia's strong stock performance over the past year, its current price-to-earnings ratio of about 23 is significantly lower than AMD's 47, highlighting its potential as a value stock, suggesting that investors should consider increasing their positions amid the current market pessimism.
See More
Blackstone Acquires Fractional AI to Form New AI Services Firm
- Acquisition Deal: Blackstone (BX), along with Anthropic (ANTHRO) and Hellman & Friedman, has acquired Fractional AI, an applied AI services company, to establish the operational core of a new firm, although financial terms remain undisclosed, this move is expected to enhance AI technology adoption in enterprises.
- Technical Alignment: As an end-to-end AI implementation partner, Fractional AI will collaborate closely with Anthropic's applied AI team to ensure technical alignment, guiding clients through their AI transformation and enhancing their competitive edge in the AI landscape.
- Market Focus: The newly formed AI services firm is tasked with assisting mid-sized companies in integrating Anthropic's Claude into their operations, reflecting a strategic emphasis on the mid-market segment, which is anticipated to provide tailored AI solutions that improve operational efficiency.
- Team Strength: Rodney Zemmel, Blackstone's global head of operations, noted that Fractional AI has become a
See More
Cirsa Reports 8% Rise in Q1 Core Earnings Amid Tax Challenges
- Core Earnings Growth: Cirsa reported a first-quarter EBITDA of €193.9 million ($225.3 million), representing an 8% increase from €178.8 million in the same period last year, indicating robust performance across multiple business units.
- Online Betting Setback: Despite overall earnings growth, Cirsa's online betting profits fell by 12% due to increased gaming taxes in Peru, posing some pressure on the company's profitability.
- 2026 Outlook Reaffirmed: Cirsa reiterated its 2026 core earnings target range of €800 million to €820 million, demonstrating confidence in future growth and an expectation to reach the upper end of this target range.
- Stock Price Volatility: Since its July 2025 listing, Cirsa's stock has shed about 11% of its value, with shares dropping as much as 2.9% in early trading, reflecting market concerns regarding its future growth potential.
See More
Apogee Therapeutics Partners with Blackstone for $1.3B Financing
- Financing Collaboration: Apogee Therapeutics has entered into a strategic financing collaboration with Blackstone Life Sciences, providing up to $1.3 billion in flexible, non-dilutive capital, including $800 million in synthetic royalty funding and $500 million in senior debt, aimed at supporting the development and commercialization of its advanced drug, zumilokibart.
- Royalty Structure: Blackstone will provide up to $800 million in synthetic royalty funding in exchange for low-to-mid single-digit tiered royalties on worldwide annual sales of zumilokibart for a term of 15 years, which is expected to generate long-term revenue for the company.
- Improved Cash Flow Outlook: As a result of this financing agreement, Apogee has removed its cash runway end date guidance, and combined with its current total cash of $1.3 billion, this transaction positions the company to achieve a self-sustainable financial profile without the need for future equity financing.
- Market Reaction: Despite the significant funding support from the agreement, the market reacted negatively, with Apogee's shares falling over 27% in premarket trading, indicating investor concerns regarding the company's future prospects.
See More
Medline Prices Upsized Secondary Offering of 72.6M Shares
- Upsized Offering: Medline announced an upsized secondary offering of approximately 72.6 million Class A shares at $37 per share, indicating sustained market demand despite the company not participating in the offering, which is expected to close on May 28.
- Underwriter Option: The selling shareholders granted underwriters a 30-day option to purchase up to an additional 10.8 million shares, enhancing market liquidity and investor confidence in Medline's stock.
- Stock Performance: Medline shares closed at $37.1 on Thursday and rose 0.8% in premarket trading on Friday, reflecting a positive market reaction to the offering announcement, which may attract more investor interest.
- Key Shareholder Background: The selling shareholders include affiliates of Blackstone, Hellman & Friedman, and a wholly owned subsidiary of the Abu Dhabi Investment Authority, showcasing strong institutional confidence and support for Medline.
See More
Private Credit Defaults Reach Record Highs Amid Rising Yields
- Rising Default Rates: Fitch Ratings reported that the U.S. private credit default rate reached a record 6.0% for the twelve months ending April 2026, up from 5.7% in March 2025, indicating a significant increase in credit risk within the sector.
- Market Tightening: As inflation concerns escalate, lenders are tightening covenant structures and standards, with KBRA noting that the market's 'narrowing margin for error' could lead to more loan defaults and refinancing challenges.
- Increased Investor Redemptions: Data from Robert A. Stanger & Co shows that redemptions from unlisted business development companies surpassed fundraising in Q1, resulting in the Stanger NL BDC Total Return Index posting its first negative return since 2022, reflecting declining investor confidence in private credit.
- Poor Performance of Major Firms: An analysis by S&P Global revealed that sentiment among the big four private equity firms has plummeted to a multiyear low, with KKR experiencing a total return decline of 19.4%, highlighting the industry's overall weak performance amid rising default rates and market uncertainty.
See More
Nvidia's Quarterly Report Sparks Market Skepticism
- Sustained Demand: CEO Jensen Huang stated that demand for Nvidia's products has gone parabolic, yet the muted market reaction to the quarterly report indicates investor skepticism about future growth, which could negatively impact stock performance.
- Data Center Business Segmentation: Nvidia has introduced a new reporting framework that segments its data center business into hyperscale and non-hyperscale customers, including AI clouds and industrial enterprises, suggesting that this segment could become a significant driver of future growth and alter market dynamics.
- Market Share Advantage: Huang emphasized that Nvidia holds nearly a 100% share in the AI cloud and industrial enterprise markets, particularly in inference computing, where rapid growth is expected to further solidify its market leadership and enhance long-term profitability.
- Valuation Appeal: Despite Nvidia's strong stock performance over the past year, its current price-to-earnings ratio of about 23 is significantly lower than AMD's 47, highlighting its potential as a value stock, suggesting that investors should consider increasing their positions amid the current market pessimism.
See More
Blackstone Acquires Fractional AI to Form New AI Services Firm
- Acquisition Deal: Blackstone (BX), along with Anthropic (ANTHRO) and Hellman & Friedman, has acquired Fractional AI, an applied AI services company, to establish the operational core of a new firm, although financial terms remain undisclosed, this move is expected to enhance AI technology adoption in enterprises.
- Technical Alignment: As an end-to-end AI implementation partner, Fractional AI will collaborate closely with Anthropic's applied AI team to ensure technical alignment, guiding clients through their AI transformation and enhancing their competitive edge in the AI landscape.
- Market Focus: The newly formed AI services firm is tasked with assisting mid-sized companies in integrating Anthropic's Claude into their operations, reflecting a strategic emphasis on the mid-market segment, which is anticipated to provide tailored AI solutions that improve operational efficiency.
- Team Strength: Rodney Zemmel, Blackstone's global head of operations, noted that Fractional AI has become a
See More
Cirsa Reports 8% Rise in Q1 Core Earnings Amid Tax Challenges
- Core Earnings Growth: Cirsa reported a first-quarter EBITDA of €193.9 million ($225.3 million), representing an 8% increase from €178.8 million in the same period last year, indicating robust performance across multiple business units.
- Online Betting Setback: Despite overall earnings growth, Cirsa's online betting profits fell by 12% due to increased gaming taxes in Peru, posing some pressure on the company's profitability.
- 2026 Outlook Reaffirmed: Cirsa reiterated its 2026 core earnings target range of €800 million to €820 million, demonstrating confidence in future growth and an expectation to reach the upper end of this target range.
- Stock Price Volatility: Since its July 2025 listing, Cirsa's stock has shed about 11% of its value, with shares dropping as much as 2.9% in early trading, reflecting market concerns regarding its future growth potential.
See More
